aaiPharma Announces Strategic Hires.

WILMINGTON, N.C. -- aaiPharma Inc. (PINK SHEETS:AAIIQ) announced today the addition of three new executives. Mr. Vito Mangiardi joins the Company as President of North American Operations, Mr. Martin Hunicutt joins the Company as Senior Vice President of Global Integrated Solutions and Mr. Pete Megronigle joins the Company as Senior Vice President of Business Development, North America. E[acute accent]With over 24 years of national and international experience, Mr. Mangiardi will oversee all of the Company's clinical and non-clinical operations in North America. Most recently, Mr. Mangiardi served as Senior Vice President and Chief Operating Officer for the Late Phase Unit for Quintiles Transnational, Inc., responsible for the management of all aspects of pharmaceutical development. Prior to this, Mr. Mangiardi served Quintiles as Senior Vice President of International Clinical Development Services. Additional leadership positions previously held by Mr. Mangiardi include President and Chief Executive Officer of Clingenix, Inc. and President and Chief Executive Operating Officer of Diagnostic Laboratories, Inc. E[acute accent]Mr. Hunicutt returns to aaiPharma to lead the Company's newly created Global Integrated Solutions division to provide bundled services according to the needs of existing or evolving market sectors. In addition, the division will manage customer service programs to ensure customer satisfaction, repeat business and program profitability. Prior to joining the Company, Mr. Hunicutt served as Executive Vice President of Marketing and Business Development for Mylan Bertek Pharmaceuticals, Inc. Prior to this, he served as Vice President of Advanced Phase Solutions and Vice President of Business Development for U.S. Account Management for Quintiles Transnational, Inc. From 1994 to 1998, he held positions of increasing responsibility at aaiPharma, including Vice President of Marketing, Sales and Business Development, President of North American Operations, and Executive Vice President of Global Business Development. E[acute accent]Pete Megronigle will apply twenty seven years of healthcare and pharmaceutical experience in operations, business development and sales, evaluation of opportunities, and strategic management to lead the Company's sales efforts in North America. Mr. Megronigle comes to us from Innovex, Inc. where he served as Vice President and Head of North American Health Management Services. Previous positions with Innovex include Regional Vice President of Business Development Japan & Korea and Vice President and Head of Business Development North America. Prior to joining Innovex, Mr. Megronigle served as Director of Client Services for Corning Besselaar/Covance responsible for business development including proactive sales, sales management, account management and proposal development. E[acute accent]"I am very pleased that these talented individuals are joining our team as we prepare to emerge from Chapter 11 and launch our new company strategy," stated Dr. Ludo Reynders, President & CEO. "They understand our company's opportunity and will add considerable breadth and depth to our management team. Their proven management skills and deep knowledge of the industry will be important assets as we rebuild aaiPharma."

E[acute accent]About aaiPharma

E[acute accent]aaiPharma Inc. is a science-based company with corporate headquarters in Wilmington, North Carolina and over 25 years' experience in drug development. The Company has capabilities in North America, Europe, and Asia, and offers product development and support services to pharmaceutical, biotechnology and generic companies worldwide. For more information on the Company, please visit aaiPharma's website at www.aaipharma.com.